The UK’s MHRA warned that inadequate electronic health record (eHR) systems are costing clinical trials by creating risks around site selection and data reconstructability. The regulator said commercial sponsors may reject NHS trusts with noncompliant eHRs during selection and that poor systems can undermine marketing authorization or journal publication through inability to reconstruct trial data, raising concerns for UK research recruitment competitiveness.